Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianlong is a China-based molecular diagnostics and in vitro diagnostics company focused on nucleic acid testing instruments, PCR systems, extraction systems, and related reagents. The company develops and manufactures integrated sample-to-answer platforms, real-time PCR instruments, automated nucleic acid extraction workstations, and assay kits used in clinical diagnostics, public health, food safety, and research. Its portfolio spans sample collection, nucleic acid extraction, PCR amplification, and result analysis, with products commercialized internationally. Tianlong appears to operate primarily as an IVD tools and diagnostics company rather than a therapeutics developer, and it markets a broad catalog of PCR-based systems and detection kits rather than a classic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianlong.